Chandler, AZ, March 28, 2008 --(PR.com
)-- Consumers who are concerned about the effects of trace pharmaceuticals can rest easier knowing that Kinetico’s drinking water treatment systems with Reverse Osmosis (RO) can reduce the amount of trace pharmaceuticals in drinking water.*
A recent CBS Evening News segment listed 26 trace pharmaceuticals found in United States drinking water supplies. These pharmaceuticals include Acetaminophen, Amoxicillin, Azithromycin, Caffeine, Carbadox, Carbamazepine, Clofibric Acid, Codeine, Cotinine, Dehydronifedipine, Diclofenac, Diphenhydramine, Estradiol, Estrone, Fluoxetine, Ibuprofen, Meprobamate, Naproxen, Phenytoin, Prednisone, Roxithromycin, Sulfamethoxazole, Sulfathiozole, Tetracycline, Tylosin, and Virginiamycin.
According to the Associated Press, three medications, including an antibiotic, were found in Arizona drinking water. This is in addition to the two recent TCE, a suspected cancer-causing chemical, contaminations in Scottsdale and Paradise Valley.
While no water treatment system can claim to eliminate all trace pharmaceuticals in drinking water, Kinetico drinking water systems with Reverse Osmosis technology are capable of reducing molecular compounds larger than 100 g/mol.
“Kinetico’s combined water treatment technologies are among the best solutions on the market,” says Shamus Hurley, President of Kinetico Incorporated. RO filtration paired with Kinetico’s additional patented contaminant reducing treatments, including the MACguard® filter, offer even greater protection and help consumers achieve a higher level of protection than RO alone.
According to the Water Quality Association, filtering systems in the home provide the highest technology available for treatment of drinking water.
Kinetico Quality Water provides residential, commercial and industrial water softeners, whole house filtration and reverse osmosis drinking water systems. For more information, contact Mike Smyser at 480-497-0488 or visit kineticoaz.com.
*“Fate of pharmaceuticals during indirect potable reuse,” BioInfoBank Institute, http://lib.bioinfo.pl/pmid:12227606, retrieved March 13, 2008.
*“ITG Subject: Reverse Osmosis,” Food and Drug Administration,
http://www.fda.gov/ora/inspect_ref/itg/itg36.html, retrieved March 13, 2008.